Northern Capital Management (Wisconsin)’s Gilead Sciences GILD Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-18,255	Closed	-$1.29M	–	154
2017 Q2	$1.29M	Sell	18,255 -8,110	-31%	-$540K	0.48%	74
2017 Q1	$1.79M	Buy	26,365 +3,115	+13%	+$219K	0.71%	58
2016 Q4	$1.67M	Buy	23,250 +240	+1%	+$17.8K	0.7%	60
2016 Q3	$1.82M	Buy	23,010 +16,465	+252%	+$1.34M	0.82%	50
2016 Q2	$546K	Buy	+6,545	New	+$581K	0.24%	103
2015 Q3	–	Sell	-1,885	Closed	-$221K	–	153
2015 Q2	$221K	Sell	1,885 -1,300	-41%	-$142K	0.1%	127
2015 Q1	$313K	Sell	3,185 -380	-11%	-$38.6K	0.15%	116
2014 Q4	$336K	Buy	+3,565	New	+$369K	0.17%	110

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s GILD Position: Q3 2017 in Review

Northern Capital Management (Wisconsin) sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 18,255 shares — an estimated $1.29M sold.

Northern Capital Management (Wisconsin) first reported a position in GILD in Q4 2014 and held it in 8 quarters. The position peaked at $1.82M in Q3 2016. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

Northern Capital Management (Wisconsin) reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
Northern Capital Management (Wisconsin) sold 18,255 Gilead Sciences shares in Q3 2017, an estimated $1.29M.
Northern Capital Management (Wisconsin) first reported a position in Gilead Sciences in Q4 2014 and held it in 8 quarters.
Northern Capital Management (Wisconsin)'s Gilead Sciences position peaked at $1.82M in Q3 2016.
1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q3 2017, filed 27 Oct 2017.